VALGANCICLOVIR HYDROCHLORIDE | A210169 | MSN LABORATORIES PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Hoffmann-La Roche Inc. et al v. Airis Pharma Private Limited 2 patentsANDA 210169valganciclovir hydrochloride | S.D.N.Y. | 2017-10-13 | Terminated 2018-07-09 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.10
per ml
Lowest NADAC/Unit
$1.10
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72205001901VALGANCICLOVIR HCL 50 MG/ML | $1.10 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.